Rasio rega marang bathi BeyondSpring Inc (BYSI)

BeyondSpring, Inc. - logo grafis emiten BYSI

The oncology sector is characterized by fierce competition with industry behemoths utilizing patent wars. BeyondSpring Inc. (BYSI) is currently seeing its share price squeezed by R&D costs and weak demand in China, with the indicator standing at -3.90. This price action for the securities on the GURU.Markets platform confirms the priced-in risks; however, BeyondSpring Inc. (BYSI) relies on its authority in developing immune support agents for chemotherapy.

BeyondSpring Pharma (BYSI) - Rasio rega marang bathi saka 04.07.2022 nganti 09.11.2026

Rincian metrik komprehensif lan analitis BeyondSpring Pharma (BYSI)

- rega lan prakiraan konsensus rega:
Rega saham beyondspringpharma.com|BYSI - Bagan rega target
- rincian kapitalisasi pasar:
Nilai pasar BeyondSpring Inc.|BYSI - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- informasi kapitalisasi buku:
Nilai Akuntansi Saham BeyondSpring|BYSI - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku beyondspringpharma.com|BYSI - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas BeyondSpring Inc.|BYSI - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas BeyondSpring Inc|BYSI - Utang perusahaan|Utang-utang marang nilai buku BeyondSpring Inc.|BYSI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BeyondSpring|Likuiditas darurat beyondspringpharma.com
- indikator bathi lan kelipatan valuasi:
BYSI - Bathi resik|Proyeksi bathi resik BeyondSpring Inc.|BYSI - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi BeyondSpring, Inc.|BYSI - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan BeyondSpring Inc.|BYSI - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan BeyondSpring|BYSI - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan beyondspringpharma.com|BYSI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep BeyondSpring Inc.
Analisis komprehensif perusahaan:BYSI (beyondspringpharma.com)
Sampel barang BeyondSpring Inc.

Investors utilize multiples to distinguish speculative movements from an asset's actual market value, verifying the issuer's long-term sustainability. The ratio of current market capitalization to annual net income, reflected through the forward P/E of BeyondSpring Inc. (BYSI), allows for an assessment of whether BeyondSpring Inc. (BYSI) is overbought given its Plinabulin patent protection and R&D partnerships, where inflated indicator values signal an increased risk of a price correction.

Analisis perusahaan pesaing

Pangali P/E incyte.com|Rasio rega marang bathi HUTCHMED (HCM)|Rasio rega marang bathi NUVB (Nuvation Bio Inc)|Day One Bio - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik MNPR|INBX - Rasio rega marang bathi|Kapitalisasi marang bathi I-Mab|Fennec Pharmaceuticals Inc. (FENC) - Rasio rega marang bathi|Pangali rega marang bathi HRTX|NVCT (Nuvectis) - Pangali P/E|Koefisien rega marang bathi coherus.com (CHRS)|Rasio rega marang bathi Corbus Pharmaceuticals (CRBP)|CRDF - Kapitalisasi marang bathi|Rasio rega marang bathi BioAtla BCAB|Lixte Biotechnology Holdings Inc. - Rasio rega marang bathi|CTXR - Rasio rega marang bathi|Kapitalisasi marang bathi Cellectar Corp|BLRX: Pangali P/E|Rasio kapitalisasi marang bathi resik canfite.com CANF|Koefisien rega marang bathi APRE|Kapitalisasi marang bathi Kazia KZIA|Koefisien rega marang bathi SLXN (Silexion Therapeutics Corp)|NCNA (nucana.com) - Nilai perusahaan marang bathi resik|Chimerix, Inc. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik CYCC (cyclacel.com)|G1 Pharma - Pangali P/E|Nilai perusahaan marang bathi resik KRON (Kronos Bio Inc)|KTRA: Pangali P/E|Kapitalisasi marang bathi Oncternal Corp (ONCT)|Rasio rega marang bathi Portage Biotech Inc.